Xtant Medical Holdings Inc. (NYSE AMERICAN: XTNT)
$0.73
+0.0200 ( +2.82% ) 46.9K
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Market Data
Open
$0.73
Previous close
$0.71
Volume
46.9K
Market cap
$94.15M
Day range
$0.67 - $0.75
52 week range
$0.60 - $1.45
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Aug 09, 2023 |
8-k | 8K-related | 14 | Aug 01, 2023 |
10-q | Quarterly Reports | 79 | Aug 01, 2023 |
8-k | 8K-related | 14 | Jul 28, 2023 |
8-k | 8K-related | 20 | Jul 28, 2023 |
8-k | 8K-related | 13 | Jul 11, 2023 |